Apimeds Pharmaceuticals signs BlockAssure deal
- October 4, 2026, agreement with BlockAssure
- 2-year contract with automatic renewals
- MindWave to build AssureChain on MindChain
APUS
Apimeds Pharmaceuticals US, Inc. SEC filings
Every EDGAR filing for Apimeds Pharmaceuticals US, Inc. (APUS), newest first, with AI summaries and stories.
- Ticker
- APUS
- CIK
- 1894525
- Sector
- Biotech and pharma
- Latest filing
- 5d
Next: 10-Q expected ~Nov 19 (deadline Nov 16)
Filings
8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 10-QApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 10-QApimeds Pharmaceuticals US, Inc.APUSLIVE NT 10-QApimeds Pharmaceuticals US, Inc.APUSLIVE SCHEDULE 13D/AApimeds Pharmaceuticals US, Inc.APUSLIVE Ownership stake disclosure by Inscobee Inc. (amended)
Inscobee Inc., filed by
8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 10-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 425Apimeds Pharmaceuticals US, Inc.APUSLIVE 8-K/AApimeds Pharmaceuticals US, Inc.APUSLIVE NT 10-KApimeds Pharmaceuticals US, Inc.APUSLIVE SCHEDULE 13D/AApimeds Pharmaceuticals US, Inc.APUSLIVE Ownership stake disclosure by Inscobee Inc. (amended)
Inscobee Inc., filed by
8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE SCHEDULE 13D/AApimeds Pharmaceuticals US, Inc.APUSLIVE Ownership stake disclosure by Inscobee Inc. (amended)
Inscobee Inc., filed by
8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-K/AApimeds Pharmaceuticals US, Inc.APUSLIVE 425Apimeds Pharmaceuticals US, Inc.APUSLIVE SCHEDULE 13GApimeds Pharmaceuticals US, Inc.APUSLIVE Ownership stake disclosure by Ayrton Capital LLC
Ayrton Capital LLC, filed by
SCHEDULE 13D/AApimeds Pharmaceuticals US, Inc.APUSLIVE Ownership stake disclosure by Inscobee Inc. (amended)
Inscobee Inc., filed by
PREM14CApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 8-K/AApimeds Pharmaceuticals US, Inc.APUSLIVE 425Apimeds Pharmaceuticals US, Inc.APUSLIVE 8-KApimeds Pharmaceuticals US, Inc.APUSLIVE 4/AApimeds Pharmaceuticals US, Inc.APUSLIVE Apimeds Pharmaceuticals US, Inc. filed 4/A
- Form Type: 4/A
- Filing Date: 2025-11-21
Inscobee Inc., reporting
8-KApimeds Pharmaceuticals US, Inc.APUSLIVE Apimeds Pharmaceuticals US, Inc. reported: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
4Apimeds Pharmaceuticals US, Inc.APUSLIVE 5 insider filings
Bennett Weintraub, insider filing for APUS
Show all 5
- 4Insider filing for APUS
- 4Insider filing for APUS
- 4Insider filing for APUS
- 4Insider filing for APUS
- 4Insider filing for APUS
Bennett Weintraub, reporting
10-QApimeds Pharmaceuticals US, Inc.APUSLIVE